Artwork

Content provided by Tjasa Zajc. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Tjasa Zajc or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Switzerland, AI and Liquid Biopsies

36:51
 
Share
 

Manage episode 414605147 series 2359900
Content provided by Tjasa Zajc. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Tjasa Zajc or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

AI and predictive modeling to understand an individual’s immune system function and predict treatment response are still in very early stages. We dream about precision medicine and getting every answer we can for ourselves when we get sick. However, if we look at genomics, only about 20 percent of human coding genes are well-studied. The remaining 80 percent (about 16,000 genes, along with the proteins they make) are largely a mystery.

In this episode, you will hear more about the field of immuno-oncology, understand the correlation between tumor development and immune system response, and trends in cancer detection and prevention, especially liquid biopsies - tests for detecting tumors in blood samples.

Speaker: Brian Hashemi - Executive Chairman and CEO of Novigenix - a Swiss-based biotech company using AI and RNA sequence analysis to capture the cancer immunity cycle during the multi-stage disease progression and response to therapy.

www.facesofdigitalhealth.com

https://fodh.substack.com/

Show notes:

[00:02:00] The use of AI and RNA sequence analysis in capturing the cancer immunity cycle and disease progression

[00:04:00] Biotech in Switzerland

[00:06:00] The impact of Swiss biotech capabilities on global healthcare and the specific advancements made by Swiss companies in the field.

[00:08:00] Predictions and hopes for the future of healthcare technology, especially in the realms of cancer detection and treatment.

[00:10:00] Challenges and opportunities in biotech, and the role of AI in advancing healthcare.

[00:12:00] Challenges in Colorectal Cancer Screening

[00:14:00] The Impact of Liquid Biopsy on Clinical Trials and Drug Development

[00:16:00] Market Adoption and Patient Accessibility to Liquid Biopsy Tests

[00:18:00] The Future of Liquid Biopsy and Precision Medicine

[00:20:00] Real-world Application and Impact of Novel Biomarkers

[00:22:00] Expanding the Reach of Novel Diagnostics Beyond Switzerland

[00:24:00] Partnerships and Collaborations to Accelerate Adoption

  continue reading

317 episodes

Artwork
iconShare
 
Manage episode 414605147 series 2359900
Content provided by Tjasa Zajc. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Tjasa Zajc or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

AI and predictive modeling to understand an individual’s immune system function and predict treatment response are still in very early stages. We dream about precision medicine and getting every answer we can for ourselves when we get sick. However, if we look at genomics, only about 20 percent of human coding genes are well-studied. The remaining 80 percent (about 16,000 genes, along with the proteins they make) are largely a mystery.

In this episode, you will hear more about the field of immuno-oncology, understand the correlation between tumor development and immune system response, and trends in cancer detection and prevention, especially liquid biopsies - tests for detecting tumors in blood samples.

Speaker: Brian Hashemi - Executive Chairman and CEO of Novigenix - a Swiss-based biotech company using AI and RNA sequence analysis to capture the cancer immunity cycle during the multi-stage disease progression and response to therapy.

www.facesofdigitalhealth.com

https://fodh.substack.com/

Show notes:

[00:02:00] The use of AI and RNA sequence analysis in capturing the cancer immunity cycle and disease progression

[00:04:00] Biotech in Switzerland

[00:06:00] The impact of Swiss biotech capabilities on global healthcare and the specific advancements made by Swiss companies in the field.

[00:08:00] Predictions and hopes for the future of healthcare technology, especially in the realms of cancer detection and treatment.

[00:10:00] Challenges and opportunities in biotech, and the role of AI in advancing healthcare.

[00:12:00] Challenges in Colorectal Cancer Screening

[00:14:00] The Impact of Liquid Biopsy on Clinical Trials and Drug Development

[00:16:00] Market Adoption and Patient Accessibility to Liquid Biopsy Tests

[00:18:00] The Future of Liquid Biopsy and Precision Medicine

[00:20:00] Real-world Application and Impact of Novel Biomarkers

[00:22:00] Expanding the Reach of Novel Diagnostics Beyond Switzerland

[00:24:00] Partnerships and Collaborations to Accelerate Adoption

  continue reading

317 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide